Substance / Medication

Cortisone

Overview

Active Ingredient
cortisone
RxNorm CUI
2878

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

4 trials linked to this intervention

4
Total Trials
1
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
[Meta-analysis of hydrocortisone in the treatment of severe community-acquired pneumonia].
Gu Xue, Yang Penglei, Yu Lina et al. · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025
PMID: 40820529Meta-Analysis
Effect of hydrocortisone-fludrocortisone combination on mortality in septic shock: a systematic review and meta-analysis.
Wu Jheng-Yen, Liu Mei-Yuan, Liu Ting-Hui et al. · Infection · 2025
PMID: 39192056Meta-Analysis
Timing of hydrocortisone therapy in neonates with shock: a systematic review, meta-analysis, and clinical practice guideline.
Ramaswamy Viraraghavan Vadakkencherry, Kumar Gunjana, Pullattayil S Abdul Kareem et al. · Front Pediatr · 2025
PMID: 40144277Meta-AnalysisFull text (PMC)
Corticosteroids for sepsis and septic shock: a meta-analysis of 18 RCTs with dose-stratified and fludrocortisone subgroup evaluation.
Ruyuan Lv, Zhangshun Shen, Hongling Li et al. · BMC Anesthesiol · 2025
PMID: 41120996Meta-AnalysisFull text (PMC)
Hydrocortisone in very preterm neonates for BPD prevention: meta-analysis and effect size modifiers.
De Luca Daniele, Ferraioli Sara, Watterberg Kristi L et al. · Arch Dis Child Fetal Neonatal Ed · 2024
PMID: 38237961Meta-Analysis
Early use of low-dose hydrocortisone can reduce in-hospital mortality in patients with septic shock: A systematic review and meta-analysis.
Song Binglin, Zheng Xiangde, Fu Kangrui et al. · Medicine (Baltimore) · 2024
PMID: 39612454Meta-AnalysisFull text (PMC)
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review.
Alekrish Yazeed, Alotaibi Mohammed, Ekhzaimy Aishah · Rev Endocr Metab Disord · 2024
PMID: 39218827Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cortisone (substance)
SNOMED CT
32498003
UMLS CUI
C0010137
RxNorm CUI
2878

Clinical Data

This intervention maps to 30 entities in the Healos knowledge graph.

20
Conditions
4
Biomarkers
4
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.